{"disease":{"id":"active-cancer","name":"active cancer"},"drugs":{"marketed":[{"drug_id":"entrectinib","indication_name":"Reactive oxygen species 1 positive non-small cell lung cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rozlytrek","generic_name":"entrectinib","company_name":"Roche","drug_phase":"marketed","molecular_target":"High affinity nerve growth factor receptor","drug_class":"","quality_score":59,"revenue":"300","mechanism":"Rozlytrek works by blocking the activity of a specific protein called the nerve growth factor receptor."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07494864","title":"Effects of Microbiological and Immunological Factors on the Lower Urinary Tract","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05830279","title":"Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT07478536","title":"Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":350,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT03283553","title":"Involving Family to Improve Communication in Breast Cancer Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT03035409","title":"Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":129,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT02435472","title":"Active Surveillance Exercise Clinical Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT07386171","title":"Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT06970353","title":"Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT03244956","title":"Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT01955408","title":"Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT05351268","title":"3DPCT Combined With CT Guided RISI in the Treatment of Thoracic Malignant Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT04560127","title":"Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT05403801","title":"STAMP+CBT mHealth for Cancer Pain","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":true}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}